{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:42:44Z","timestamp":1777444964010,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":3321,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1593\/neo.04559","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T03:13:36Z","timestamp":1119928416000},"page":"417-425","source":"Crossref","is-referenced-by-count":44,"title":["LY293111 Improves Efficacy of Gemcitabine Therapy on Pancreatic Cancer in a Fluorescent Orthotopic Model in Athymic Mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Rene","family":"Hennig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacinthe","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Segersvard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Zhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambasiva M.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borko D.","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Talamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Bell Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1593\/neo.04559_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics, 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1593\/neo.04559_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2188\/jea.8.52","article-title":"Descriptive epidemiology of pancreatic cancer in Japan","volume":"8","author":"Lin","year":"1998","journal-title":"J Epidemiol"},{"key":"10.1593\/neo.04559_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00006676-199804000-00005","article-title":"The epidemiology of pancreatic diseases in Japan","volume":"16","author":"Oomi","year":"1998","journal-title":"Pancreas"},{"key":"10.1593\/neo.04559_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0147-0272(96)80001-8","article-title":"Pancreatic adenocarcinoma","volume":"20","author":"Howard","year":"1996","journal-title":"Curr Probl Cancer"},{"key":"10.1593\/neo.04559_bib5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s002689900598","article-title":"Improving results of pancreaticoduodenectomy for pancreatic cancer","volume":"23","author":"Yeo","year":"1999","journal-title":"World J Surg"},{"key":"10.1593\/neo.04559_bib6","first-page":"725","article-title":"Surgical management of pancreatic cancer","volume":"16","author":"Ahrendt","year":"2002","journal-title":"Oncology (Huntington)"},{"key":"10.1593\/neo.04559_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000055290","article-title":"Gemcitabine: progress in the treatment of pancreatic cancer","volume":"60","author":"Heinemann","year":"2001","journal-title":"Oncology"},{"key":"10.1593\/neo.04559_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/cncr.10753","article-title":"New applications of gemcitabine and future directions in the management of pancreatic cancer","volume":"95","author":"Abbruzzese","year":"2002","journal-title":"Cancer"},{"key":"10.1593\/neo.04559_bib9","first-page":"3232","article-title":"Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells","volume":"8","author":"Tong","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.04559_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9440(10)64198-3","article-title":"5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue","volume":"161","author":"Hennig","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.04559_bib11","first-page":"465","article-title":"The leukotriene B4 receptor antagonist, LY293111 induces apoptosis through the mitochondrial pathway in human pancreatic cancer cells","volume":"23","author":"Tong","year":"2001","journal-title":"Pancreas"},{"key":"10.1593\/neo.04559_bib12","first-page":"453","article-title":"Involvement of the MAPK and PI3 kinase pathways in leukotriene B4 stimulated human pancreatic cancer cell proliferation","volume":"25","author":"Tong","year":"2002","journal-title":"Pancreas"},{"key":"10.1593\/neo.04559_bib13","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1593\/neo.04559_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2222.2000.00092.x","article-title":"The role of eosinophils and neutrophils in inflammation","volume":"30","author":"Sampson","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1593\/neo.04559_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000055827","article-title":"Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer","volume":"1","author":"Ding","year":"2001","journal-title":"Pancreatology"},{"key":"10.1593\/neo.04559_bib16","first-page":"1","article-title":"Role of lipoxygenase pathways in the regulation of pancreatic cancer cell proliferation and survival","volume":"00","author":"Ding","year":"2001","journal-title":"Inflammopharmacology"},{"key":"10.1593\/neo.04559_bib17","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/jm00022a006","article-title":"Synthetic and structure\/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-ropoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist","volume":"38","author":"Sawyer","year":"1995","journal-title":"J Med Chem"},{"key":"10.1593\/neo.04559_bib18","first-page":"286","article-title":"Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies","volume":"288","author":"Jackson","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1593\/neo.04559_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2133.2000.03295.x","article-title":"VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis","volume":"142","author":"Mommers","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1593\/neo.04559_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0006-2952(96)00884-2","article-title":"The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111)","volume":"53","author":"van Pelt","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1593\/neo.04559_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2133.1998.02401.x","article-title":"Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis","volume":"139","author":"van Pelt","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1593\/neo.04559_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00006676-200010000-00014","article-title":"Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression","volume":"21","author":"Ding","year":"2000","journal-title":"Pancreas"},{"key":"10.1593\/neo.04559_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/carcin\/21.6.1121","article-title":"Biologic instability of pancreatic cancer xenografts in the nude mouse","volume":"21","author":"Schmied","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1593\/neo.04559_bib24","first-page":"1534","article-title":"Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model","volume":"62","author":"Bouvet","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.04559_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1470-2045(02)00848-3","article-title":"Green fluorescent protein imaging of tumour growth, metastasis, angiogenesis in mouse models","volume":"3","author":"Hoffman","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1593\/neo.04559_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/excr.1994.1075","article-title":"Extracellular matrix components regulating glandular differentiation and the formation of basal lamina of a human pancreatic cancer cell line in vitro","volume":"211","author":"Yamanari","year":"1994","journal-title":"Exp Cell Res"},{"key":"10.1593\/neo.04559_bib27","first-page":"54","article-title":"Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9","volume":"78","author":"Iwamura","year":"1987","journal-title":"Jpn J Cancer Res"},{"key":"10.1593\/neo.04559_bib28","first-page":"1206","article-title":"P-selectin expression in a metastatic pancreatic tumor cell line (SUIT- 2)","volume":"57","author":"Iwamura","year":"1997","journal-title":"Cancer Res"},{"key":"10.1593\/neo.04559_bib29","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1073\/pnas.052029099","article-title":"Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model","volume":"99","author":"Yang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.04559_bib30","first-page":"80","article-title":"Efficacy of camptothecin analog DX-8951f (exatecan mesylate) on human pancreatic cancer in an orthotopic metastatic model","volume":"63","author":"Sun","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.04559_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1006326203858","article-title":"Orthotopic metastatic mouse models for anti-cancer drug discovery and evaluation: a bridge to the clinic","volume":"17","author":"Hoffman","year":"1999","journal-title":"Invest New Drugs"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558605800739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558605800739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T20:21:17Z","timestamp":1548361277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558605800739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1476558605800739"],"URL":"https:\/\/doi.org\/10.1593\/neo.04559","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}